Table 1

Standard Protocol Items: Recommendation for Interventional Trials (SPIRIT)

	Study period
	Hospital stay	Hospital discharge	Follow-up			Close-out
TIME POINT	−1 to −7 days	0	M3	M6	M9	M12
ENROLMENT
Eligibility screen	X
Informed consent	X
INTERVENTIONS
Medication reconciliation		X*
Medication review		X
Interview before discharge		X*
Providing educational brochures, discharge plan, medication plan		X*
Providing follow-up diary		X
Information sharing with healthcare professionals		X*	X*	X*	X*	X*
Telephone interviews			X*	X*	X*
Final interview						X
ASSESSMENTS
History, demographics		X
PRIMARY OUTCOME
Medication possession ratio			X*	X*	X*	X
Adherence scale		X				X
SECONDARY OUTCOMES
Blood glucose control		X				X
Lipid control		X				X
Abdominal girth		X				X
Blood pressure		X				X
Quality of life (SF-36)		X				X
Belief/representation about the disease (Brief IPQR)		X				X
Knowledge about the disease and the treatments		X				X
Lifestyle		X				X
Number, type and severity of iatrogenic events						X
Proportion of patients having recurrent stroke or other major adverse cardiovascular event						X
Proportion of patients readmitted to hospital						X
Adherence to each secondary preventive drug						X
Patient satisfaction regarding treatments (SATMED-Q)						X
Patient satisfaction regarding the intervention programme						X*
Community pharmacist’s satisfaction regarding the intervention programme						X*
General practitioner’s satisfaction regarding the intervention programme						X*

*Intervention group.
Brief IPQR, Brief Illness Perception Questionnaire; SATMED-Q, Treatment Satisfaction with Medicines Questionnaire; SF-36, Short Form 36 Health Survey questionnaire.